HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claus Belka Selected Research

erucylphospho- N,N,N- trimethylpropylammonium

10/2012Effects of ionizing radiation in combination with Erufosine on T98G glioblastoma xenograft tumours: a study in NMRI nu/nu mice.
11/2010The Akt-inhibitor Erufosine induces apoptotic cell death in prostate cancer cells and increases the short term effects of ionizing radiation.
10/2009Pharmacokinetics and biodistribution of Erufosine in nude mice--implications for combination with radiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Claus Belka Research Topics

Disease

143Neoplasms (Cancer)
03/2022 - 01/2003
42Prostatic Neoplasms (Prostate Cancer)
01/2022 - 07/2005
29Squamous Cell Carcinoma of Head and Neck
06/2022 - 01/2008
28Glioblastoma (Glioblastoma Multiforme)
04/2022 - 12/2003
26Glioma (Gliomas)
08/2021 - 08/2006
25Neoplasm Metastasis (Metastasis)
01/2022 - 03/2012
21Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 08/2004
20Head and Neck Neoplasms (Head and Neck Cancer)
03/2022 - 04/2005
13Hypoxia (Hypoxemia)
03/2022 - 05/2004
11Brain Neoplasms (Brain Tumor)
01/2022 - 09/2012
11Breast Neoplasms (Breast Cancer)
01/2022 - 03/2014
9Carcinoma (Carcinomatosis)
04/2021 - 10/2004
9AIDS-Related Complex (ARC)
01/2021 - 01/2018
9Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2020 - 09/2012
8Sarcoma (Soft Tissue Sarcoma)
01/2022 - 06/2010
7Lymphoma (Lymphomas)
07/2022 - 05/2003
7Lung Neoplasms (Lung Cancer)
08/2021 - 01/2018
7Adenocarcinoma
01/2021 - 12/2007
7Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 07/2010
6Hyperthermia
03/2021 - 04/2003
5Unilateral Breast Neoplasms
08/2021 - 01/2018
5Necrosis
02/2021 - 03/2014
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2020 - 03/2011
5Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 01/2009
4Squamous Cell Neoplasms (Squamous Cell Cancer)
07/2021 - 04/2005
4Meningioma (Meningiomas)
01/2021 - 11/2009
3Pancreatic Neoplasms (Pancreatic Cancer)
06/2022 - 02/2020
3Hepatocellular Carcinoma (Hepatoma)
05/2021 - 05/2018
3Pneumonia (Pneumonitis)
01/2021 - 09/2006
3Melanoma (Melanoma, Malignant)
02/2020 - 01/2017
3Margins of Excision
04/2017 - 07/2015
3Leukemia
11/2010 - 03/2007
2Myeloid Leukemia (Leukemia, Myelocytic)
08/2022 - 12/2021
2Inflammation (Inflammations)
03/2022 - 12/2009
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 09/2018
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 05/2020
2Second Primary Neoplasms (Neoplasms, Second)
01/2022 - 01/2017
2Disease Progression
01/2022 - 01/2021
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2021 - 12/2019
2Heart Diseases (Heart Disease)
08/2021 - 01/2019
2Rectal Neoplasms (Rectal Cancer)
03/2021 - 09/2011

Drug/Important Bio-Agent (IBA)

14LigandsIBA
01/2022 - 03/2003
12Temozolomide (Temodar)FDA LinkGeneric
04/2022 - 04/2011
12Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2016
11DNA (Deoxyribonucleic Acid)IBA
01/2022 - 09/2005
11Cisplatin (Platino)FDA LinkGeneric
04/2021 - 04/2005
10Bevacizumab (Avastin)FDA Link
09/2019 - 01/2012
9Biological ProductsIBA
01/2022 - 03/2003
8Proteins (Proteins, Gene)FDA Link
03/2022 - 10/2008
8Protons (Proton)IBA
01/2022 - 10/2011
8AntigensIBA
01/2022 - 05/2018
7Pharmaceutical PreparationsIBA
01/2022 - 03/2007
6Immune Checkpoint InhibitorsIBA
01/2022 - 01/2019
6Iodine-125IBA
02/2021 - 03/2012
5Cetuximab (Erbitux)FDA Link
07/2021 - 01/2008
5Oxygen (Dioxygen)IBA
11/2019 - 05/2004
5MicroRNAs (MicroRNA)IBA
01/2019 - 03/2011
5Death Domain ReceptorsIBA
03/2010 - 05/2003
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2010 - 03/2003
4RNA (Ribonucleic Acid)IBA
03/2022 - 10/2008
4gallium 68 PSMA-11IBA
01/2021 - 11/2017
4Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 10/2004
4Irinotecan (Camptosar)FDA LinkGeneric
09/2019 - 10/2016
4Celecoxib (Celebrex)FDA Link
01/2010 - 08/2003
3fluoromisonidazoleIBA
01/2022 - 01/2017
3AndrogensIBA
01/2021 - 01/2008
3durvalumabIBA
01/2021 - 04/2020
3Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2020 - 11/2015
3MethyltransferasesIBA
09/2019 - 10/2016
3erucylphospho- N,N,N- trimethylpropylammoniumIBA
10/2012 - 10/2009
3CaspasesIBA
09/2010 - 02/2003
3Antineoplastic Agents (Antineoplastics)IBA
03/2010 - 02/2004
3Caspase 8 (Caspase-8)IBA
03/2007 - 05/2003
3Caspase 3 (Caspase-3)IBA
06/2005 - 05/2003
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
08/2022 - 12/2021
2Messenger RNA (mRNA)IBA
04/2022 - 12/2018
2Chemokine ReceptorsIBA
12/2021 - 08/2017
2CytokinesIBA
12/2021 - 01/2019
2PlatinumIBA
07/2021 - 04/2020
2Hormones (Hormone)IBA
03/2021 - 03/2014

Therapy/Procedure

148Radiotherapy
07/2022 - 04/2003
73Therapeutics
06/2022 - 01/2003
55Chemoradiotherapy
04/2022 - 12/2007
21Drug Therapy (Chemotherapy)
06/2022 - 12/2003
16Re-Irradiation
02/2021 - 04/2005
15Brachytherapy
01/2022 - 04/2005
9Proton Therapy
02/2022 - 01/2015
9Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
08/2021 - 07/2005
8Prostatectomy (Retropubic Prostatectomy)
01/2021 - 08/2008
7Neoadjuvant Therapy
03/2021 - 01/2008
7Combined Modality Therapy
04/2020 - 01/2011
6Cranial Irradiation
01/2020 - 12/2015
5Immunotherapy
01/2022 - 02/2020
4Salvage Therapy
01/2021 - 02/2009
4Adjuvant Radiotherapy
04/2019 - 09/2008
4Segmental Mastectomy (Lumpectomy)
01/2019 - 01/2015
3Conformal Radiotherapy
08/2021 - 09/2016
3Lymph Node Excision (Lymph Node Dissection)
01/2021 - 11/2011
2Precision Medicine
01/2022 - 01/2021
2Castration
10/2021 - 03/2021